January 13, 2022

VUMC in the news, Jan. 18, 2022

A roundup of a few recent stories from the press about Vanderbilt University Medical Center:

William Schaffner, MD, professor of Preventive Medicine, continues to be one of the most in-demand sources about COVID-19, influenza and other subjects in the news. The emergence of the omicron variant has especially given him opportunities to speak to reporters and provide information and context. Among the news organizations he has spoken with recently: The New York Times, Consumer Reports, Healthline, Prevention, Kaiser Health News, and Men’s Health.

Nashville Post reporter Kathryn Rickmeyer interviewed Jeff Balser, MD, President and CEO of Vanderbilt University Medical Center and Dean of the Vanderbilt University School of Medicine, for a story about the agreement announced last week between Illumina and Nashville Biosciences.

Buddy Creech, MD, director, of the Vanderbilt Vaccine Research Program, was interviewed about the omicron variant by Yahoo! News, Newsweek and International Business Times.

Scripps interviewed James Antoon, MD, PhD, assistant professor of Pediatrics, about the development of croup in children with COVID-19.

“CBS Evening News” correspondent Norah O’Donnell interviewed Jennifer Andrews, MD, medical director of the VUMC Blood Bank, for a story about the nationwide blood shortage.

New York Times Magazine reporter Megan Stack interviewed Robert Miller, MD, associate professor of Medicine, for a story about his research into burn pits and soldiers who came back from deployment with respiratory issues.

HLN producer Sonja Van Sacker interviewed Shichun Bao, MD, PhD, associate professor of Medicine at the Vanderbilt Eskind Diabetes Clinic, via Zoom for a story about personal glucose monitors.

Matthew Schrag, MD, PhD, assistant professor of Neurology, was quoted in a Washington Post story about Medicare coverage for Alzheimer’s disease drugs.